Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

PDE4-inhbitory pyridines disclosed by Janssen

Oct. 27, 1999

No Comments

Polyethoxylated retinamides superior to known retinoic acid derivatives for skin aging

Oct. 25, 1999

No Comments

Wound-healing agent reaches the market in U.K.

Oct. 25, 1999

No Comments

FDA okays new antipsoriatic for clinical testing

Oct. 22, 1999

No Comments

Retinoid receptor-active compounds from Galderma for skin disorders

Oct. 21, 1999

No Comments

Vasogen cleared to proceed with psoriasis clinical trial

Oct. 21, 1999

No Comments

Dusa updates Levulan PDT development

Oct. 18, 1999

No Comments

Idec commences phase I/II study with IDEC-114 for treatment of psoriasis

Oct. 7, 1999

No Comments

BMS and Gillette seek approval for Vaniqa in the U.S.

Oct. 7, 1999

No Comments

Abgenix completes phase I/II clinical trial with ABX-IL-8

Oct. 6, 1999

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Dermatologic
RSS

PDE4-inhbitory pyridines disclosed by Janssen

Polyethoxylated retinamides superior to known retinoic acid derivatives for skin aging

Wound-healing agent reaches the market in U.K.

FDA okays new antipsoriatic for clinical testing

Retinoid receptor-active compounds from Galderma for skin disorders

Vasogen cleared to proceed with psoriasis clinical trial

Dusa updates Levulan PDT development

Idec commences phase I/II study with IDEC-114 for treatment of psoriasis

BMS and Gillette seek approval for Vaniqa in the U.S.

Abgenix completes phase I/II clinical trial with ABX-IL-8

Today's news in brief

Today's news in brief

STAT6 stat sig? Kaken, J&J $1.2B-plus deal adds oomph to space

GLP-1 receptor agonists continue their global victory tour

Type 1 diabetes breakthrough? Sana threads key ‘islet,’ SC-451 to advance

Dermatologic RSS

Dermatologic
RSS